Category: Clinical Trials

The summary of the phase 2 clinical trial of Cediranib on Alveolar Soft Part Sarcoma

If you consider to join the following clinical trial: Sunitinib or Cediranib for Alveolar Soft

Dear ASPS community. Many of our patients who participated in Cediranib clinical trials reported on

  Please note the two Phase II clinical trials available for ASPS patients in the

Dear ASPS Community, We are very happy to report the opening of another clinical trial

Cediranib (Recentin, AZD2171) is an inhibitor of VEGF (Vascular Endothelial Growth Factor) receptors. Therefore, the

The GVAX cancer vaccine clinical trial, which has been opened in January 2006 is no

ArQule Achieves Clinical Milestone in MiT Trial with ARQ 197 Thursday October 2, 8:01 am

Previously, we reported that Alveolar Soft Part Sarcoma is a candidate for therapy by drugs